R&D News | pharmaphorum

News

Reducing levels of LDL-cholesterol can reduce the risk of dementia by 26%, and statins could add to the benefit, according to a just-published study.

News

Reduction in force (RIF) job losses have started in earnest at US federal agencies, including the FDA and CDC, according to media reports.

News

EVERSANA has joined the growing roster of companies partnering with Veeva on the development of GenAI applications for the life sciences industry.

News

AstraZeneca reveals phase 2b results with its oral PCSK9 inhibitor AZD0780 as it tries to narrow a lead held by MSD with its rival cholesterol drug.

News

Mineralys looks odds on to become the first drug developer to bring an aldosterone synthase inhibitor to market for uncontrolled hypertension.

News

Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine and advance its pipeline.